QUEENSBURY, N.Y., Jan 07, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 14, 2010 at 1:30 p.m. Pacific Time. Jan Keltjens, President and CEO, will review the Company's business strategy and historical financial results.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's Web site at: http://investors.angiodynamics.com. The archived presentation will be available for 90 days.

About AngioDynamics

AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

SOURCE: AngioDynamics, Inc.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Investor Relations:
Doug Sherk or Jenifer Kirtland, 415-896-6820
dsherk@evcgroup.com
jkirtland@evcgroup.com
Media:
Chris Gale, 646-201-5431
cgale@evcgroup.com

Copyright Business Wire 2010